ETF · holdings as of 2026-10-24

What's inside PBE?

Invesco Biotechnology & Genome ETF
Holdings
30
positions in the fund
Top 10
49%
of fund assets
Expense ratio
0.58%
net, per year
Fund size
$282M
total net assets
Hold PBE alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Sectors tap a row to see its top 10 holdings
Top holdings — Health Care
Your 10 largest positions in this sector
1
N
NTRANATERA INC
6.00%
2
I
ILMNILLUMINA INC
5.99%
3
B
BIIBBIOGEN INC
5.68%
4
G
GILDGILEAD SCIENCES INC
5.24%
5
R
RPRXROYALTY PHARMA PLC- CL A
5.14%
6
A
AMGNAMGEN INC
4.97%
7
R
REGNREGENERON PHARMACEUTICALS
4.83%
8
V
VRTXVERTEX PHARMACEUTICALS INC
4.74%
9
M
MRNAMODERNA INC
3.44%
10
Q
QGENQIAGEN N.V.
3.15%
Geography tap a row to see its top 10 holdings
Top holdings — United States
Your 10 largest positions in this country
1
N
NTRANATERA INC
6.00%
2
I
ILMNILLUMINA INC
5.99%
3
B
BIIBBIOGEN INC
5.68%
4
G
GILDGILEAD SCIENCES INC
5.24%
5
A
AMGNAMGEN INC
4.97%
6
R
REGNREGENERON PHARMACEUTICALS
4.83%
7
V
VRTXVERTEX PHARMACEUTICALS INC
4.74%
8
M
MRNAMODERNA INC
3.44%
9
H
HALOHALOZYME THERAPEUTICS INC
3.13%
10
E
EXELEXELIXIS INC
3.10%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Funds similar to PBE